Active, Not Recruiting
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
NCT05148871
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- ARASMI Adelaide, South Australia, Australia